« FDA Approvals - Investigational Drug Paliperidone ER Significantly Delayed Symptom Recurrence In Clinical | Main | FDA Approves New Biologic Treatment for Wet Age-Related Macular Degeneration »

Kos seeks FDA OK for Niaspan caplets (Pharmaceutical Business Review)


Kos seeks FDA OK for Niaspan caplets (Pharmaceutical Business Review)
Kos Pharmaceuticals has submitted a supplemental new drug application to the FDA for a complete dosage range of Niaspan caplet formulation products.
 

©2006 FDA-News.com. All rights reserved.